Skip Navigation



Radiation Protection Dosimetry Advance Access published online on March 24, 2006
Radiation Protection Dosimetry, doi:10.1093/rpd/nci528
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
120/1-4/171    most recent
nci528v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schultka, K.
Right arrow Articles by Jassem, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schultka, K.
Right arrow Articles by Jassem, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

SSD 2005 Special Issue Articles

EPR/ALANINE DOSIMETRY IN LDR BRACHYTHERAPY--A FEASIBILITY STUDY

Katarzyna Schultka 1 *, Bartlomiej Ciesielski 1, Krystyna Serkies 2, Tomasz Sawicki 2, Zofia Tarnawska 2, and Jacek Jassem 2

1 Department of Physics and Biophysics, Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland
2 Department of Oncology and Radiotherapy, Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland

* To whom correspondence should be addressed.
Katarzyna Schultka, E-mail: kschult{at}amg.gda.pl


  Abstract

In this study, we present the results of in vivo dosimetry, using electron paramagnetic resonance in L-alanine, performed on 13 patients treated for gynaecological cancers. The doses from 137Cs (12 samples) and 192Ir (one sample) brachytherapy sources were determined inside vagina. The detectors had a form of small cellulose capsules tightly filled with crystalline alanine. The positions of the detectors were reconstructed from two orthogonal radiographs. The planned doses were calculated with a computer planning system (PLATO, Nucletron). The relative deviations between planned and measured doses ranged from -23 to +14%. The mean deviation from the prescribed dose was relatively low (-5%) with SD of 10%. The main sources of differences between the measured and calculated doses were attributed to uncertainty in the determination of the detector position inside the patient's body and to uncontrolled changes in the detector position during the treatment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.